UK Independent Finance Intelligence · Est. 2024
Updated daily Newsletter For business
Home Hub: Insurance Travel Insurance With Diabetes UK 2026
Hub: Insurance

Travel Insurance With Diabetes UK 2026

CT
Chandraketu Tripathi
Finance Editor, Kaeltripton
Published 11 May 2026
Last reviewed 11 May 2026
✓ Fact-checked
Travel Insurance With Diabetes UK 2026

Photo by NisonCo PR and SEO on Unsplash

Advertisement

TL;DR: Diabetes is one of the most commonly declared pre-existing conditions on UK travel insurance applications. Insurers assess whether the condition is Type 1 or Type 2, current HbA1c control, medication type, and any recent complications or hospitalisations. Well-controlled diabetes is typically insurable; poorly controlled diabetes or recent complications may require specialist insurer assessment. Full declaration under the Consumer Insurance (Disclosure and Representations) Act 2012 is legally required.

KEY FACTS
  • NHS England data indicates that over 4.3 million people in the UK are living with a diabetes diagnosis, making it one of the most prevalent conditions declared on travel insurance applications (nhs.uk).
  • The Consumer Insurance (Disclosure and Representations) Act 2012, at legislation.gov.uk, requires applicants to take reasonable care not to misrepresent their medical history, including a diabetes diagnosis and any related complications.
  • The FCA's Consumer Duty (PS22/9, effective July 2023, fca.org.uk) requires insurers and distributors to ensure products are fair in value and genuinely meet the needs of customers with pre-existing conditions including diabetes.
  • The ABI requires insurers and comparison platforms to signpost applicants to specialist providers where they cannot offer suitable cover for a declared condition such as diabetes (abi.org.uk).
  • The UK GHIC, available free from the NHS Business Services Authority at nhsbsa.nhs.uk, provides access to state healthcare in EU and EEA countries but does not cover repatriation, private care, or cancellation costs.

How Insurers Assess Diabetes: Type, Control and Complications

Diabetes assessment in travel insurance underwriting distinguishes between Type 1 and Type 2 diabetes because the risk profile differs between the two. Type 1 diabetes involves complete insulin dependence, a higher risk of hypoglycaemic episodes, and typically longer duration of management. Type 2 diabetes varies significantly: it may be managed through diet alone, oral medication such as metformin, or insulin therapy. Insurers ask a structured series of questions to categorise the risk. These questions typically cover the type of diabetes, the current medication and whether insulin is used, whether HbA1c has been measured recently and the result, whether the applicant has been hospitalised or attended A and E for a diabetic episode in the past 12 to 24 months, and whether any complications are present. Diabetic complications including neuropathy, retinopathy, nephropathy, and cardiovascular disease are each relevant to the underwriting assessment and must be declared separately. Well-controlled diabetes, defined by stable HbA1c within an acceptable range, no recent hospital admissions for diabetic episodes, and no significant complications, is generally assessed favourably by most mainstream insurers. Poorly controlled diabetes, or diabetes with significant associated complications such as renal impairment or recent cardiovascular events, is more likely to result in loading, exclusion of related claims, or referral to specialist underwriters. Insulin-dependent travellers should also note that insulin is a temperature-sensitive medication; insurers may factor in the logistical risks of managing insulin on long-haul or high-temperature travel when assessing the application.

Declaration Requirements: Diabetes and Associated Conditions

Declaring diabetes on a travel insurance application requires more than naming the primary condition. Diabetic complications and comorbidities are frequently the source of medical emergencies abroad and must each be declared individually. Cardiovascular disease, hypertension, and kidney disease that arise in the context of diabetes are separate declarable conditions. Failing to declare a diabetic complication because the applicant considers it part of the same underlying diabetes can constitute a material non-disclosure. The Consumer Insurance (Disclosure and Representations) Act 2012 requires applicants to take reasonable care not to misrepresent, and the obligation extends to all conditions that a medical screening questionnaire asks about. If a screening question asks about heart conditions and the applicant has diabetes-related cardiovascular disease, that must be declared under the heart condition question as well as the diabetes question. The Financial Ombudsman Service has confirmed in published guidance that for non-disclosure to justify full repudiation of a claim, the insurer must demonstrate the non-disclosure was deliberate or reckless. For innocent non-disclosure, the insurer may adjust the settlement to what it would have paid had full disclosure been made. In practice, a traveller who fails to declare diabetic nephropathy and subsequently requires emergency dialysis abroad may find their claim reduced to what the insurer would have paid had the kidney complication been declared, which may be significantly less than the full cost of treatment.

Insulin, Medication and Travelling Abroad with Diabetes

The practical management of diabetes during travel is a significant consideration that connects directly to the insurance coverage required. Insulin requires refrigeration and can degrade if exposed to excessive heat or cold, both of which are risks in checked luggage. NHS guidance advises insulin-dependent travellers to carry all insulin in hand luggage, use an insulated cooling wallet, and carry twice the quantity needed in case of delays or loss. A letter from the GP or diabetes specialist confirming the diagnosis, the insulin regimen, and the need to carry needles and lancets is advisable for passing through airport security in the UK and abroad. Some insulin types, or other diabetes medications such as GLP-1 receptor agonists, may have specific import requirements in certain countries. The UK Government's foreign travel advice at gov.uk/foreign-travel-advice carries country-specific entry and health information. Time zone changes affect insulin timing and dose schedules; the NHS advises travellers to discuss adjustments with their diabetes team before departure. From an insurance standpoint, a policy that covers declared diabetes should cover emergency treatment for hypoglycaemia, diabetic ketoacidosis, or other acute episodes abroad up to the policy's medical emergency limit. MoneyHelper guidance recommends a minimum medical emergency limit of £2 million for European travel and higher for long-haul destinations; for insulin-dependent diabetics travelling to the United States, where hospital costs are very high, the highest available limits are advisable.

Specialist Travel Insurance for Complex or Poorly Controlled Diabetes

Where mainstream insurers apply a full diabetes exclusion or decline to quote due to poor control or significant complications, specialist medical travel insurance providers offer an alternative. The MoneyHelper directory at moneyhelper.org.uk lists specialist providers for pre-existing conditions including complex diabetes cases. BIBA's find-a-broker service at biba.org.uk connects applicants with brokers experienced in high-risk medical travel cover. Specialist insurers typically require a more detailed application, which may include the most recent HbA1c result, the insulin regimen and units per day, a list of all diabetes-related complications and their current status, and confirmation of the most recent specialist review. This additional detail allows specialist underwriters to price the risk more accurately and, in many cases, to include diabetes-related emergency claims that mainstream insurers would exclude. For travellers with Type 1 diabetes and good control, specialist cover is often available at a loading that reflects the real statistical risk rather than a blanket category exclusion. Travellers with Type 2 diabetes managed on oral medication and stable for 12 months or more have the widest range of options, including many mainstream insurers. Those on insulin for Type 2 diabetes with good control occupy a middle ground, and comparing both mainstream and specialist quotes is advisable to find the most appropriate cover at a competitive premium.

GHIC, FCDO Advice and Destination Risk for Diabetic Travellers

Travellers with diabetes should consider destination-specific factors that may influence both the practical management of the condition and the appropriateness of the insurance cover. The UK GHIC, free from the NHS Business Services Authority at nhsbsa.nhs.uk, covers medically necessary state healthcare in EU and EEA countries, providing a financial safety net for emergency hospital admission in Europe. However, access to the specific insulin type prescribed in the UK may not be guaranteed in all European hospitals, and the GHIC does not cover repatriation or private facilities. Outside the EU and EEA, particularly in destinations without reciprocal healthcare arrangements, the full cost of emergency diabetic treatment falls to the traveller without adequate insurance cover. The FCDO's country-specific travel advice at gov.uk/foreign-travel-advice is the authoritative UK government source for health risks by destination, including information on medical facility standards. Travellers with diabetes travelling to regions with elevated risk of gastrointestinal illness should be aware that vomiting and diarrhoea significantly complicate blood glucose management and can precipitate a diabetic emergency; travel health advice from a GP or travel clinic before departure is advisable for high-risk destinations.

Editorial Disclaimer: Kaeltripton.com is an independent editorial publisher and is not authorised or regulated by the Financial Conduct Authority. Content is for informational purposes only and does not constitute financial, investment, tax, legal or regulatory advice. Always verify rates and product details with the relevant provider, the FCA register, HMRC or the Bank of England before any financial decision.

Frequently Asked Questions

Do I need to declare Type 2 diabetes managed only by diet?

Yes, if the screening questionnaire asks about diabetes or metabolic conditions. Diet-controlled Type 2 diabetes is a diagnosed medical condition and falls within the definition of a pre-existing condition used by most UK travel insurers. The impact on premium or cover terms may be minimal, but the obligation to declare under the Consumer Insurance (Disclosure and Representations) Act 2012 applies regardless of how the condition is managed.

Will travel insurance cover a hypoglycaemic episode abroad?

Only if diabetes was declared and included in the policy. A declared and accepted diabetes condition should be covered for emergency medical treatment including a hypoglycaemic episode requiring hospital attendance. A policy where diabetes was excluded, or where it was not declared, will not cover the associated treatment costs. Checking the policy schedule to confirm what is included for the declared condition before travelling is important.

How do I carry insulin safely when travelling by air?

NHS guidance advises carrying all insulin in hand luggage to avoid temperature extremes in the hold, using an insulated cooling wallet, and carrying a GP letter confirming the prescription and the need to carry needles and lancets. Sufficient insulin for the entire trip plus a contingency supply should be taken. Travellers should confirm their airline's requirements for carrying liquid medication and sharps before travel.

Can I get travel insurance for diabetes with kidney complications?

Yes, though the options and cost will vary significantly depending on the severity of renal impairment. Specialist medical travel insurers, accessible via the MoneyHelper directory at moneyhelper.org.uk, are more likely to consider complex cases involving multiple diabetic complications than mainstream providers. Both the diabetes and the kidney complication must be declared separately. The underwriting assessment will consider the full clinical picture including current renal function, dialysis requirement, and transplant status if applicable.

What is the minimum medical emergency cover limit for a diabetic traveller going to the USA?

MoneyHelper guidance recommends a minimum of £2 million for European travel and higher limits for long-haul destinations. For the United States, where hospital costs for emergency admissions can be very high, the maximum available medical emergency limit is advisable for any traveller with a pre-existing condition such as diabetes. The exact limit to select depends on the policy terms, the insurer's advice, and the planned duration of stay.

How We Verified This Guide

This guide was researched against primary UK sources including NHS guidance on diabetes and travel at nhs.uk, the Consumer Insurance (Disclosure and Representations) Act 2012 via legislation.gov.uk, the FCA Consumer Duty policy statement PS22/9 at fca.org.uk, the MoneyHelper travel insurance directory at moneyhelper.org.uk, the ABI's medical conditions signposting guidance at abi.org.uk, the Financial Ombudsman Service's non-disclosure guidance at financial-ombudsman.org.uk, and the NHS Business Services Authority GHIC pages at nhsbsa.nhs.uk. Last reviewed May 2026 by Chandraketu Tripathi, finance editor at Kaeltripton.

Sources

Advertisement

Editorial Disclaimer

The content on Kaeltripton.com is for informational and educational purposes only and does not constitute financial, investment, tax, legal or regulatory advice. Kaeltripton.com is not authorised or regulated by the Financial Conduct Authority (FCA) and is not a financial adviser, mortgage broker, insurance intermediary or investment firm. Nothing on this site should be construed as a personal recommendation. Rates, figures and product details are indicative only, subject to change without notice, and should always be verified directly with the relevant provider, HMRC, the FCA register, the Bank of England, Ofgem or other appropriate authority before any financial decision is made. Past performance is not a reliable indicator of future results. If you require regulated financial advice, please consult a qualified adviser authorised by the FCA.

CT
Chandraketu Tripathi
Finance Editor · Kaeltripton.com
Chandraketu (CK) Tripathi, founder and lead editor of Kael Tripton. 22 years in finance and marketing across 23 markets. Writes on UK personal finance, tax, mortgages, insurance, energy, and investing. Sources: HMRC, FCA, Ofgem, BoE, ONS.

Stay ahead of your money

Free UK finance guides, rate changes and money-saving tips — straight to your inbox. No spam, unsubscribe anytime.

Read More

Get Kael Tripton in your Google feed

⭐ Add as Preferred Source on Google